Earnings summaries and quarterly performance for Bunge Global.
Executive leadership at Bunge Global.
Board of directors at Bunge Global.
Adrian Isman
Director
Anne Jensen
Director
Carol Browner
Director
Christopher Mahoney
Director
Eliane Aleixo Lustosa de Andrade
Director
Jay Winship
Director
Kenneth Simril
Director
Linda Jojo
Director
Mark Zenuk
Chair of the Board
Markus Walt
Director
Monica McGurk
Director
Research analysts who have asked questions during Bunge Global earnings calls.
Heather Jones
Heather Jones Research
6 questions for BG
Manav Gupta
UBS Group
6 questions for BG
Salvator Tiano
Bank of America
6 questions for BG
Steven Haynes
Morgan Stanley
6 questions for BG
Andrew Strelzik
BMO Capital Markets
5 questions for BG
Derrick Whitfield
Texas Capital
5 questions for BG
Thomas Palmer
Citigroup Inc.
5 questions for BG
Benjamin Theurer
Barclays Corporate & Investment Bank
3 questions for BG
Pooran Sharma
Stephens Inc.
3 questions for BG
Ben Toyrer
Barclays
2 questions for BG
Puran Sharma
Stevens Inc.
2 questions for BG
Andrew Stravik
BMO Capital Markets
1 question for BG
Rahi Parikh
Barclays
1 question for BG
Tami Zakaria
JPMorgan Chase & Co.
1 question for BG
Recent press releases and 8-K filings for BG.
- Third-quarter net sales rose 72% to $22.15 billion on volume growth and the Viterra acquisition.
- Net income declined to $166 million from $221 million a year earlier.
- Adjusted EPS of $2.27 topped analyst estimates.
- Company maintained full-year adjusted EPS guidance of $7.30–$7.60.
- Announced a $545 million share repurchase program to support shareholder value.
- Delivered adjusted EPS of $2.27 and adjusted EBIT of $924 million in Q3 2025, despite reported EPS of $0.86 including mark-to-market and transaction charges.
- First quarter operating as a combined Bunge-Viterra entity, with reportable segments realigned into soybean processing, softseed processing, other oilseeds processing, and grain merchandising and milling to enhance end-to-end value-chain integration.
- Reaffirmed full-year 2025 adjusted EPS guidance of $7.30–$7.60 (second-half EPS of $4.00–$4.25), with net interest expense expected at $380–$400 million and capital expenditures of $1.6–$1.7 billion.
- Year-to-date generated $1.2 billion of adjusted funds from operations and $900 million of discretionary cash flow; deployed $324 million to dividends, $903 million to growth CapEx, and repurchased 6.7 million shares for $545 million.
- At quarter-end, net debt exceeded readily marketable inventories by ~$900 million, adjusted leverage was 2.2×, and $9.7 billion of committed credit facilities remained unused.
- Adjusted EPS of $2.27 in Q3 2025 was essentially flat year-over-year, while net income per diluted share from continuing operations declined to $0.86 from $1.56 a year ago.
- Adjusted Segment EBIT rose to $924 million (Q3 2024: $559 million) and Adjusted Total EBIT increased to $757 million (Q3 2024: $491 million), driven by integration benefits.
- Maintained full-year 2025 guidance for adjusted EPS of $7.30–$7.60, including H2 EPS of $4.00–$4.25, with a 23–25% tax rate, $380–$400 million net interest expense, $1.6–$1.7 billion capex and ~$710 million D&A.
- Management noted favorable industry trends but highlighted ongoing uncertainty from macroeconomic, trade and biofuel policy dynamics.
- Reported Q3 EPS of $0.86 and adjusted EPS of $2.27, with adjusted segment EBIT rising to $924 million from $559 million year-over-year.
- Completed first quarter operating as a combined company with Viterra, realizing early integration benefits across origination and processing and capturing initial commercial synergies.
- Maintains full-year 2025 adjusted EPS guidance of $7.30–$7.60, with H2 adjusted EPS expected at $4.00–$4.25; 2025 capex is pegged at $1.6–$1.7 billion and net interest expense at $380–$400 million.
- Generated approximately $1.2 billion of YTD adjusted funds from operations and repurchased 6.7 million shares for $545 million, with $255 million remaining under the Viterra buyback program.
- First quarter operating post-Viterra integration drove end-to-end value chain efficiencies and delivered strong commodity origination, processing, and merchandising performance.
- Q3 adjusted EPS was $2.27 versus $2.29 year-ago and adjusted EBIT reached $924 million versus $559 million prior year.
- Year-to-date through Q3 generated $1.2 billion adjusted funds from operations; after $282 million sustaining CapEx, had $900 million discretionary cash, deployed $324 million dividends, $903 million growth CapEx, and $545 million in share repurchases; adjusted leverage was 2.2×.
- Maintained full-year 2025 adjusted EPS guidance of $7.30–$7.60 with Q4 expected at $4.00–$4.25, and forecasts 23–25% tax rate, $380–$400 million net interest expense, $1.6–$1.7 billion CapEx, $710 million D&A.
- GAAP EPS from continuing operations of $0.86, down from $1.56 in Q3 2024; adjusted EPS of $2.27 vs. $2.29 a year ago.
- Adjusted Total EBIT of $757 million, up from $491 million in Q3 2024.
- Net income attributable to Bunge of $166 million, compared with $221 million in the prior year quarter.
- Repurchased $545 million of shares during the quarter.
- Maintained full-year 2025 adjusted EPS guidance of $7.30–$7.60, with second-half EPS expected at $4.00–$4.25.
- Bunge reported net sales of $22,155 million in Q3 2025, up from $12,908 million a year earlier, reflecting the Viterra integration.
- GAAP diluted EPS from continuing operations was $0.86 versus $1.56 in Q3 2024; adjusted EPS was $2.27 versus $2.29.
- Repurchased $545 million of shares during the quarter.
- Affirmed full-year 2025 adjusted EPS guidance of $7.30–$7.60, with H2 adjusted EPS expected at $4.00–$4.25.
- Bunge Global shares jumped over 11% after President Trump threatened to ban U.S. imports of Chinese cooking oil, a key renewable fuels input.
- China has ceased buying U.S. soybeans since May, turning to suppliers like Argentina and Brazil amid escalating trade tensions.
- The U.S. accounted for 43% of record Chinese exports of used cooking oil last year, but shipments to the U.S. fell to $356 million in H1 2025.
- Bunge cut its 2025 earnings guidance to $7.30–$7.60 per share (analysts expected $7.39), yet the forecast remains slightly above consensus.
- Bunge’s integration with Viterra is progressing exceptionally well, with teams already identifying and capturing cost savings and commercial synergies across end-to-end value chains.
- Beginning in Q3 2025, Bunge will report four segments—soybean processing and refining; softseed processing and refining; other oilseeds processing and refining; and grain merchandising and milling—to reflect tighter upstream/downstream linkages and Viterra’s expanded footprint.
- The company has recast its full-year 2025 adjusted EPS outlook to $7.30–$7.60 (second-half EPS of $4.00–$4.25), excluding significant synergy savings and now incorporating Viterra results.
- Bunge will restate historical segment data for its legacy operations only; Viterra’s pre-acquisition results will not be separately disclosed, with detailed segment performance to be provided after the Q3 earnings call on November 5.
- Viterra integration progressing; new segment structure effective Q3 2025 introduces commodity-based reporting for enhanced transparency.
- Re-segmentation into Soybean Processing & Refining, Softseed Processing & Refining, Other Oilseeds Processing & Refining, and Grain Merchandising & Milling aligns with end-to-end value chain.
- Volume reporting recast to detail commodity-specific processing, refining and third-party sales under the new structure.
- FY 2025 adjusted EPS guidance set at $7.30–$7.60, with 2H EPS of $4.00–$4.25 on ~166 million and ~197 million weighted-average shares, respectively.
Quarterly earnings call transcripts for Bunge Global.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more
Let Fintool AI Agent track Bunge Global's earnings for you
Get instant analysis when filings drop